Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 14, 2024

Treatment Modifiers Across Different Regimens of Natalizumab Treatment in Patients With MS



Additional Info

Disclosure statements are available on the authors' profiles:

Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
Neurotherapeutics 2024 Feb 26;[EPub Ahead of Print], S Ruggieri, A Ianniello, M Copetti, M Altieri, D Centonze, A Cortese, L De Giglio, R Fantozzi, C Tortorella, C Gasperini, LM Grimaldi, D Landi, GA Marfia, M Mirabella, R Nistri, V Nociti, O Oddo, S Romano, G Salemi, M Salvetti, C Pozzilli, M Petracca

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading